These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hematopoietic stem cell transplant as a platform for tumor immunotherapy. Fuchs EJ; Whartenby KA Curr Opin Mol Ther; 2004 Feb; 6(1):48-53. PubMed ID: 15011781 [TBL] [Abstract][Full Text] [Related]
26. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies. Chang YJ; Zhao XY; Huang XJ Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899 [TBL] [Abstract][Full Text] [Related]
27. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y; Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494 [TBL] [Abstract][Full Text] [Related]
28. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
29. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
30. [Hematopoietic stem cell transplantation (HSCT): characteristics of HSCT using bone marrow, peripheral blood and cord blood cells]. Sakamaki H Rinsho Ketsueki; 2003 May; 44(5):283-93. PubMed ID: 12822402 [No Abstract] [Full Text] [Related]
31. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. Foss FM Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113 [TBL] [Abstract][Full Text] [Related]
32. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704 [TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449 [TBL] [Abstract][Full Text] [Related]
34. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Diaz MA; Vicent MG; Gonzalez ME; Verdeguer A; de la Rubia J; Bargay J; de Arriba F; Diez JL; Caballero D; Madero L; Brunet S; Bone Marrow Transplant; 2004 Sep; 34(5):433-8. PubMed ID: 15273704 [TBL] [Abstract][Full Text] [Related]
35. A history of bone marrow transplantation. de la Morena MT; Gatti RA Immunol Allergy Clin North Am; 2010 Feb; 30(1):1-15. PubMed ID: 20113883 [TBL] [Abstract][Full Text] [Related]
36. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]. Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503 [TBL] [Abstract][Full Text] [Related]
37. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Chan GW; Gorgun G; Miller KB; Foss FM Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467 [TBL] [Abstract][Full Text] [Related]
39. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312 [TBL] [Abstract][Full Text] [Related]
40. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease. Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]